Smith & Nephew plc (LON: SN.)

Market Cap	8.60B
Revenue (ttm)	4.46B
Net Income (ttm)	241.34M
Shares Out	871.98M
EPS (ttm)	0.28
PE Ratio	35.73
Forward PE	13.56
Dividend	0.30 (3.05%)
Ex-Dividend Date	Oct 3, 2024

Volume	1,622,022
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	8.87 - 12.45
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 7, 2024

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1856
• Employees: 18,452
• Stock Exchange: London Stock Exchange
• Ticker Symbol: SN.

Financial Performance

In 2023, Smith & Nephew's revenue was $5.55 billion, an increase of 6.40% compared to the previous year's $5.22 billion. Earnings were $263.00 million, an increase of 17.94%.

Financial numbers in USD